medigraphic.com
ISSN 1561-3046 (Electronic)

2018, Number 1

<< Back Next >>

Rev Cub Med Mil 2018; 47 (1)

Relationship between the human being evolutionary process and his predisposition to cancer

Pérez CAE, Benítez SE, García MD

Language: Spanish
References: 48
Page: 58-72
PDF size: 114.06 Kb.


ABSTRACT

Cancer has become the leading cause of morbidity and mortality in many countries. In recent decades there has been a change in the conceptual paradigm of neoplastic diseases, which now focuses on the ecological-evolutionary perspective of these. With the aim of analyzing, with updated elements, the relationship between the evolutionary process of the human being and his predisposition to cancer, a systematic review of the literature was made, based on three databases, Medline, Scopus, and SciELO. Consistency attributes of the reviewed articles were taken into account, studies with levels IV and V of evidence and those of insufficient quality were excluded. The current accumulated searches suggest the need to see the various neoplasms from the perspective of the dynamics of complex systems and their evolutionary implications. The human evolutionary process has biosocial peculiarities that predispose it to suffer malignant tumors. Bipedal posture increased vulnerability to the oncogenic effect of ultraviolet radiation. Sexual behavior increased the risk of contracting oncogenic virus infections. The transition to a predominantly meat and the introduction of cooking, resulted in the incorporation of xenobiotic agents whose metabolism derives carcinogens. The postponement of human aging became in a longer time for the accumulation of mutations. Modifications in the sexual and reproductive pattern in women have influenced their predisposition to breast cancer. In the population genesis of cancer underlying biosocial foundations linked to the evolutionary process of the species.


REFERENCES

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):359-86.

  2. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends-An Update. Cancer Epidemiol Biomarkers Prev. 2016 Jan-Dec [cited 2017 Feb 27];25(1):33-42. Available from: http://cebp.aacrjournals.org/cgi/pmidlookup?view=long&pmid=26667886

  3. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. July 25 2016 [cited 2017 Feb 27];4:609-16. Available from: https://www.clinicalkey.com/#!/content/playContent/1-s2.0- S2214109X16301437?returnurl=null&referrer=null

  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Ca Cancer J Clin. 2011 Aprl; 61:69-90.

  5. Curado MP, Bezerra de Souza DL. A Global Perspective on Cancer Burden in Latin America and the Caribbean. Ann Glob Hea. 2014 Sep-Oct;80(5):370-7.

  6. Iglesias-Armenteros A, Suárez-Rodríguez A. Incidencia de cáncer: cifras alarmantes. Revista Finlay [Internet].2015[citado 27 Feb 2017];5(1):[aprox.2p.].Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/345/1387.

  7. Wu C, Wang HY, Ling S, Lu X. The ecology and evolution of cancer: The ultramicroevolutionary process. Annu Rev Genet. 2016 Nov 23;50:347-69.

  8. Mateo F, Heppner GH, Miller BE, Joyce JA, Wilburg D, Terrence W, et al. SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations. Mol Cancer. 2014;13:237.

  9. Korolev KS, Xavier JB, Gore J. Turning ecology and evolution against cancer. Nat Rev Cance.r 2014;14:371-80.

  10. Heppner G. Tumor cells societies. J Natl Cancer Instit. 1989;81:648-9.

  11. Vincent JP, Fletcher AG, Baena-Lopez LA. Mechanisms and mechanics of cell competition in epithelia. Nat Rev Mol Cell Biol. 2013;14:581-91.

  12. Lu P, Weaver V, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 2012;196:395-406.

  13. Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14:275-91.

  14. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423-37.

  15. Cao Z, Ding BS, Guo P, Lee SB, Butter JM, Casey SC, et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell. 2014;25:350-65.

  16. Dawkins R. The Extended Phenotype. Oxford: University Press; 1982.

  17. Collier JD, Muller SJ. The Dynamical Basis of Emergence in natural Hierarchies. In: Farre G. Oksala T (eds). Emergence, Complexity, Hierarchie, and Organization, Acta Polytecnica Scandinavica, MA91, Finish Academic of Technology, Spoo; 1998. p. 350-5.

  18. Higgings PT, Altman DG, Sterne AC. Assessing risk of bias in included studies. 2011 March; Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) [cited 2017 Feb 27]. Available from: http://es.cochrane.org/sites/es.cochrane.org/files/public/uploads/manual_cochrane _510_web.pdf

  19. Jablonski D, Bottjer D. The ecology of evolutionary innovation: the fossil record. In: Nittecki MH (ed.). Evolutionary Innovations. Chicago: University of Chicago Press; 1990.

  20. De Vita Jr V, Chu E. Medical oncology. En: Cancer Principles & Practice of Oncology. Philadelphia: Walters Klumer Health/ Lippincott Williams & Wilkins; 2011. p.312-22.

  21. Nitecki M, Nitecki D. Origins of Anatomically Modern Humans. Nueva York: Plenum; 1994.

  22. Bickers D. Fotosensibilidad y otras reacciones a la luz. En: Harrison's, Principles of internal medicine; 19a. ed. New York: Editorial McGraw-Hill; 2013. p.350-5.

  23. Hoek KS, Goding CR. Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 2010;23:746-59.

  24. Pérez Alejo JL, Miranda Leyva R. Radiaciones electromagnéticas y salud en la investigación médica. Rev Cubana Med Mil [Internet]. 2010 mar [citado 08 dic 2017];39(1):[aprox.13 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 65572010000100005&lng=es

  25. ButkIiewicz D, Cole KJ, Phillips DH, Harris CC, Chorazi M. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur J of Cancer Prevention. 2012;8:315-23.

  26. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS. 2012;263(1):131-3.

  27. Coon MJ, Ding X, PerneckySJ, Vaz A. Cytochrome P450: progress and predictions. FASEB J. 1992;6:669-73.

  28. Quinones L, Lee K, Varela FN, Escala M, Garcia K, Godoy L, Castro A, Soto J, Saavedra I, Caceres D. Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure. Rev Med Chile. 2006;134(4):499-515.

  29. Prufer K, Munch K, Hellmann J, Akani K, Miller JR, Walenz B, et al. The bonobo genome compared with the chimpanzee and human genomes. Nature. 2012;486:527-31.

  30. Woodman CB, Collins SL, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007;7:11.

  31. Kutok J, Wang F. Spectrum of Epstein Barr virus-associated deseases. Annu Rev Pathol. 2006;1:375.

  32. Grassmann R, Aboud M, Jeang KT. Molecular mechanism of cellular transformation by HTLV-1 tax. Oncogene. 2005;24:5976.

  33. Wang J, Xie G, Singh M, Ghanbarian AT, Raskó T, Szvetnik A, et al. Primatespecific endogenous retrovirus-driven transcription defines naive-like stem cells. Nature. 2014 Dec 18 [cited 2016 Jun 20];516(7531):405-9. Available from: https://www.nature.com/articles/nature13804

  34. Gifford WD, Pfaff SL, Macfarlan TS. Transposable elements as genetic regulatory substrates in early development. Trends in Cell Biology. May 2013;23(5):253-8.

  35. Gibb EA, Warren LM, Wilson GW, Brown SD, Robertson GA, Morin GB, Holt RA. Activation of endogenous retrovirus- associated long non- coding RNA in human adenocarcinoma. Genome Medicine. 2015;7(1):22.

  36. Longo D, Fauci SA. The human retroviruses. En: Harrison's, Principles of internal medicine. 16 ed. New York: Editorial McGraw-Hill; 2013. p. 1030-71.

  37. Sarin R. A decade of discovery of BRCA1 and BRCA2: Are we turning the tide against hereditary breast cancers? J Cancer Res Ther. 2007;2:157-8.

  38. Zakaria S, Degnim AC. Prophylactic mastectomy. SurgClin N Am. 2007;87:317- 31.

  39. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kubela J, Kubela PM, Postovit LM. Reprogramming metastatic tumor cells with embryonic microenvironments. Nat Rev Cancer. 2007;7:246-55.

  40. Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest. 2012;122:2983-8.

  41. Rausch T, Jones DT, Zapatka M, Sturtz AM, Zichner T, Weischenfieldt J, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell. 2012;148:59-71.

  42. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789-99.

  43. Moriri PJ, Trent JM, Collins FS, Vogelstein B. Aspectos genéticos del cáncer. En: Harrison's. Principles of internal medicine. 19 ed. New York: Editorial Mc Graw Hill Interamericana; 2013.p.498-519.

  44. Diamond J. The Third Chimpanzee. New York: Harper Collins; 1992.

  45. Brown JS, Aktipis CA. Inclusive fitness effects can select for cancer suppression into old age. Phil. Trans. R. Soc. 2015 [cited 12 Apr 2017];B370:20150160. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581037/

  46. Perls T, Terry D. Understanding the determinants of exceptional longevity. Ann Intern Med. 2003;139:445.

  47. Graves M. Evolutionary determinants of cancer. Cancer Discov. 2015 Aug;5(8):806-20.

  48. Diamond J. ¿Por qué el sexo es divertido?. Madrid: Editorial Debate; 1999.




2020     |     www.medigraphic.com